The offer consists of 300 million euros in an immediate cash payment, structured on a cash-free and debt-free basis, with an additional 50 million euros tied to performance milestones extending through 2027. IPG Photonics intends to finance the purchase entirely through existing cash reserves. The acquisition requires a mandatory information and consultation process with Lumibird’s works council, a procedural necessity under French labor regulations, before the parties finalize a definitive agreement.
In section Market Quotes
IPG Photonics Bids 350 Million Euros for Lumibird Medical
IPG Photonics has moved to acquire Lumibird Medical in a deal valued at up to 350 million euros, or $400.6 million. The proposed transaction aims to bolster the buyer's presence in the medical technology sector by integrating specialized ophthalmology expertise with its existing urology portfolio.
CEO Mark Gitin stated that the move is designed to create a scaled medical platform capable of accelerating innovation and expanding commercial reach. According to the company, the integration adds roughly $1 billion to its addressable market and is expected to provide an immediate boost to both gross margins and adjusted earnings.
Comments (0)
No comments yet. Be the first!